Promoter collection, Human RB1 promoter
Alternative name | U2734(2112)-3 |
---|---|
Clone info. | PCR amplified human RB1 promoter sequence was inserted into a firefly luciferase vector. Cloned fragment: 48302465 to 48303797(NC_000013.11); relatively -1282 to +51, where +1 corresponds to 1 nt of NM_000321.2. |
Comment | PCR cloning, forward primer: GACGAGTTCAGATGGGCAAT; reverse primer: AACGTCCCCTGAGAAAAACC. Genomic fragment 48,302,464 to 48,303,797 of NC_000013.11 is cloned. Known difference: deletion of 5 nt of 48,302,963 to 48,302,967; T to G substitution at 48,303,180. |
Vector backbone | pGL4.10 [Luc2] (Plasmid) |
Selectable markers | Amp^r |
Gene/insert name | Human retinoblastoma 1 genomic DNA |
Depositor|Developer | DNA Bank, | |
Remarks, protocol and/or map (pdf) | RDB07345.pdf |
---|
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms | Order form [Credit Card Payment] [Bank Transfer Payment] [Example of order form ] MTA, for use for not-for-profit academic purpose [Word] [Example of MTA ] Please visit Information of Request for Distribution.[link] |
---|---|
Terms and conditions for distribution | In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. Additional terms and conditions: The use of the BIOLOGICAL RESOURCE is restricted to the academic researches conducted by non-profit organization. By using this material, the RECIPIENT agrees to be bound by the conditions of the limited use statement of the Promega Corporation. |
必要書類 | 提供依頼書 [依頼書の記入例 ] 提供同意書 (MTA, 非営利学術目的用)[Word] [MTAの記入例 ] 手続きの概要は、「提供申込みについて[link]」をご覧ください。 |
---|---|
MTAに書く使用条件 | 謝辞の表明を必要とする。 MTAに書く付加的使用条件: 本件リソースの使用は学術機関での学術研究に限る。本件リソースの使用にあたって、利用者はプロメガ社の限定使用条件に従う必要がある。 |
Catalog # | Resource name | Shipping form | Fee (non-profit org.) |
---|---|---|---|
RDB07345 | pGL4-phRB1 | DNA solution |
Materials & Methods section:
The pGL4-phRB1 was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB07345). |
Reference section:
Further references such as user reports and related articles (go to bottom)
RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by icon as well as clone information before placing your order.
Test sheet | RDB07345_A5Gu.pdf |
---|
Nucleotide sequence of a portion of this resource (if available).
Primer: pGL4-4174F Sequence file: RDB07345_A5Gua.seq |
---|
>07345_07345_A5Gu_pGL4-4174F_C04_07.ab1 1 ACTGGGGCAG GACATTTCTC TGGCCTAACT GGCCGGTACC TGAGCTCGCT AGCCTCGAGG 61 ATGACGAGTT CAGATGGGCA ATAACAGTGT CTGCCAAAGA GAAAAAAAAA TGTATTCAAA 121 CTAGATAATC TATTGGTACA AATACCGAGA CACAGAAGTG ATAACAGCTT TAAGCCAATG 181 TTTGATGGTG GTAGTCCCAG CAAGCTCTTT TCTGATGTCT TTGTGCCTTT GCACATGCTC 241 CTTCTCTGTC ACTGTTTTCT TCATCAAACA TAATATAATG GACAAGTGGA ATCAAATAGA 301 ATTGAGTTCA AATTCTCTGC TACCCATCGG CCCTGGTATT GGACAAATTA ACTCCTCTGA 361 GCCTGTTTCC TCATCTGCAA CGTAGACTAG CTAATACTAC CCATTGGAAA GCGTTGTTTC 421 TTAGCTAATG CATGCAAGGC TTAAAACCTA GATGACGGGT TGATAGGTGC AGCAAACCTC 481 CATGGCATAC GTATGCCTAT GTAACAAACC TACACGTTCT GCACTTGTAT CCCGGAACTT 541 AAAGTAAAAA AAAAAAAAAA AAAAGAAAGA AAGAAAAAGA AAAAAAAGGC TGTTTCTGGG 601 GATTAAATAA GACAATTATG TAAGGTGGCC AGCACAGTTC CTGGTACATA GTAAATGTCA 661 GGCCTGCCTG ACAGACTTCT ATTCAGCAGC TACTGCTCCC CTGAAAATCT TCCTCAGACG 721 TTTCCACGGT GCTTCCCGTT CTTACACCAC TACAATCCTT TATTACACTA CTCTCCGTTC 781 ATTCCCCACA GCTCCCTCCC TTCCTTTCCC TAACCAGTGA TCCCAAAAGG CCAGCAAGTG 841 TCTAACATTT TCTATCTTCT AAGTGACTGG TAAAGTTCCG CACCTATCAG CGCTCCAAGT 901 TTGTTTTTGT TTTGGCCGAC TTTGCAAAAC GGATTGGGCG GGATGAGAGG TGGGGGGCGC 961 CGCCCAAAGG AGGGAGAGTG GCGCTCCCGC CGAGGGTGCA CTAGCCAGAT ATTCCCTGCG 1021 GGGCCCGAGA GTCTTCCCTA TCAGACCCCG GGATAGGATG AGCCCACAGT CACCCCACCA 1081 GACTCTTGTA TAGCCCCGAT TAAGTGCACC CGACCTTGCA AGGGGTGGCT CTGGCTAGGA 1141 GGCACCGTCC GGGGCTCG // |
Primer: pGL4-136R Sequence file: RDB07345_A5Gub.seq |
>07345_07345_A5Gu_pGL4-136R_D04_10.ab1 1 GCTATGTTTT GGCATCTTCC ATGGTGGCTT TACCAACAGT ACCGGATTGC CAAGCTTGGC 61 CGCCGAGGCC AGATCTTGAT AACGTCCCCT GAGAAAAACC GGACGCGCCC TCCCCCGCCC 121 GGCAACTGAG CGCCGCGTCC AACCGCGGGA AAACGTCACT TCCGCCCGCG GCGTCACGTC 181 CGCGAGGCTC CCGGGCCCGC CGGCGTCTGT GGGGAACTGG GGCGCTGGTC GGTGCGCGGG 241 CTGGGACGCT AAGTCATGAG GAATTAAACT GGGAAACCTG GCGTGGGTCC AGGCGCCTTC 301 CAGGAGGCAT CCGGCGCGGC CCGGACGTGC TTCTACCCAG AACCACCCCC TCCAGGCCGG 361 GGTGCACTTA ACGGGGCTAT ACAAAGAGTC TGGTGGGTGA CTGTGGGCCT CATCCCTATC 421 CCGGGGTCTG ATAGGGAAGA CTCTCGGGCC CCGCAGGGAA TATCTGGCTA GTGCACCCTC 481 GGCGGGAGCG CCACTCTCCC TCCTTGGGCG GCGCCCCCCA CCTCTCATCC CGCCCAATCC 541 GTTTTGCAAA GTCGGCCAAA ACAAAAACAA ACTTGGAGCG CTGATAGGTG CGGAACTTTA 601 CCAGTCACTT AGAAGATAGA AAATGTTAGA CACTTGCTGG CCTTTTGGGA TCACTGGTTA 661 GGGAAAGGAA GGGAGGGAGC TGTGGGGAAT GAACGGAGAG TAGTGTAATA AAGGATTGTA 721 GTGGTGTAAG AACGGGAAGC ACCGTGGAAA CGTCTGAGGA AGATTTTCAG GGGAGCAGTA 781 GCTGCTGAAT AGAAGTCTGT CAGGCAGGCC TGACATTTAC TATGTACCAG GAACTGTGCT 841 GGCCACCTTA CATAATTGTC TTATTTAATC CCCAGAACAG CCTTTTTTTT CTTTTTCTTT 901 CTTTCTTTTT TTTTTTTTTT TTTTACTTTA AGTTCCGGGA TACAAGTGCA GAACGTGTAG 961 GTTTGTTACA TAGGCATACG TATGCCATGG AAGGTTTGCT GCACCTATCA ACCCGTCATC 1021 TAAGGTTTTA AAGCCCTTGC ATGCATTAGC TAAGAAAACA ACGCTTTCCC AAATTGGGGT 1081 AGGTATTAGC CTTAGTCTTA CGGTGGCAGA TGAAGCAAAC AGGCTCAGAG GAGTTTAATT 1141 TGGTCCAAAT ACCCAAG // |
Please visit Sequencing and PCR primers for primer information.
Original, user report and related articles
Featured content